About Us
Research
Medtech / Biopharma
Healthcare Payers / Providers
Macro / Misc.
Request Access
Login
Biopharma / Medtech Reports
January 6, 2025
Conference Policy Prep Pack: Devices, Diagnostics, & Tools
•
John Leppard
BSX (US)
,
DXCM (US)
,
EW (US)
,
EXAS (US)
,
GH (US)
,
GKOS (US)
,
INSP (US)
,
MDT (US)
December 20, 2024
EW: Tricuspid Coverage Positive, With Some Caveats
•
John Leppard
ABT (US)
,
EW (US)
December 17, 2024
[GRAL, EXAS, GH] Multi-Cancer Test Coverage: Details Fall Flat
•
John Leppard
EXAS (US)
,
GH (US)
,
GRAL (US)
December 11, 2024
[EW, ABT] Tricuspid Coverage Expectations
•
John Leppard
ABT (US)
,
EW (US)
December 10, 2024
DXCM vs ABT in Updated ADA Guidelines
•
John Leppard
ABT (US)
,
DXCM (US)
December 3, 2024
Life Science Tools: NIH Cuts in Context
•
John Leppard
AVTR (US)
,
BRKR (US)
,
DHR (US)
,
ILMN (US)
,
MTD (US)
,
QGEN (US)
,
RVTY (US)
,
TMO (US)
November 27, 2024
LLY, NVO, HIMS: GLP-1 Coverage Questions & Implied Sales
•
John Leppard
HIMS (US)
,
LLY (US)
,
NVO (US)
November 26, 2024
[LLY, NVO] Quick Takes on Obesity Coverage Surprise
•
John Leppard
LLY (US)
,
NVO (US)
November 26, 2024
Exact Sciences: Cologuard Plus Gets 16% Bump, Coverage Questions Remain
•
John Leppard
EXAS (US)
,
GH (US)
November 25, 2024
RFK’s Medical Coding Reforms: Don’t Hold Your Breath
•
John Leppard
ABT (US)
,
BSX (US)
,
NARI (US)
,
TFX (US)
«
1
2
3
4
»